ROT-TDS, Neupro 8 mg/24 h transdermal patch, Neupro 8 mg/24 h transdermal patch
1462rot25ct
Phase 2 small_molecule active
Quick answer
ROT-TDS, Neupro 8 mg/24 h transdermal patch, Neupro 8 mg/24 h transdermal patch for Parkinson's disease is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Parkinson's disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active